<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20210219050410N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2021-07-20</date_registration>
      <primary_sponsor>Shahroud University of Medical Sciences</primary_sponsor>
      <public_title>Comparing the Effectiveness of Kegel Exercises and Paula Method on the Severity of Stress Urinary Incontinence in Aged Women in Virtual Training: A Parallel Randomized Clinical Trial</public_title>
      <acronym></acronym>
      <scientific_title>Comparing the Effectiveness of Kegel Exercises and Paula Method on the Severity of Stress Urinary Incontinence in Aged Women in Virtual Training: A Parallel Randomized Clinical Trial</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-04-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>114</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/54439</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Supportive, Other design features: Training instructions and follow-ups will be implemented virtually, Randomization description: Patients will be divided into three groups (two in intervention groups and one in control group) through randomization and based on the production of random numbers strings through software. (www.randomizer.org)
In order for the number of assignments to each group to be equal, the block method of volume 6 is used to create a random allocation sequence because participants are gradually entered into the study.
The allocation concealment will be done centrally. In this way, the assignment sequence will be done by someone outside the research team. Upon each person entering the study, the researcher will contact the person and assign the person to the group.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Stress urinary incontinence.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Paula method, which includes a group of circular muscle exercises to return proper functioning of the body, allows to strengthen the pelvic floor muscles by contracting and expanding the circular muscles in other parts of the body such as the eyes, lips, hands and nose. Paula method will be taught to the elderly people via CD and a link to download educational videos and brochures, and the elderly people will be asked to do this method for 12 weeks and every week for 45 minutes. People are encouraged to perform this method daily for 15-45 minutes. Treatment companions can also contact the person in charge of the investigation in case of any questions or problems. Intervention 2: Intervention group: Kegel exercises is the contraction and expansion of the pelvic floor muscles and leads to strengthening of the pelvic floor muscles. These exercises last for 8 weeks and 10 sets a day. Each time involves 10-12 seconds of contraction and 10-12 seconds of rest. Intervention 3: Control group will receive the routine intervention in treatment centers.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Some of the patients' demographic information can be shared after unidentifying individuals. All the results of the pad test, ultrasound and urinary incontinence questionnaire can be shared with caregivers after unidentiﬁed individuals.

When:
After publishing the article

To whom:
Project partners

Conditions:
People who do similar research

Where to obtain:
It will be done by email with the person in charge of the project

How to obtain:
The data will be available to individuals via email

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Haniyeh Ezzatmoghaddam</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Haft-e Tir Sq, Shahroud University of Medical Sciences, Shahroud, Iran</address>
        <city>Shahroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3614773947</zip>
        <telephone>+98 23 3239 5054</telephone>
        <email>h.moghadam@shmu.ac.ir</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ali Dadgari</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Haft-e Tir Sq, Shahroud University of Medical Sciences, Shahroud, Iran</address>
        <city>Shahroud</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>3614773947</zip>
        <telephone>+98 23 3239 5054</telephone>
        <email>dadgari@shmu.ac.ir</email>
        <affiliation>Shahroud University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All 60-year-old and above female cases referred to health centers
Women with moderate to severe stress urinary incontinence based on ICIQ-UISF questionnaire
Women with MMSE scores above 12 for cognitive abilities
Women with urine leakage at least one gram/hour in the pad test</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>no limit</agemax>
      <gender>Female</gender>
      <exclusion_criteria>Women treated with other similar exercises over the last year
Women under medications with side-effect on bladder function
Women diagnosed cases of oregonomegaly
Women with a previous history of surgery for urinary incontinence
Women with a history of pelvic radiation therapy during the last 5 years
Women with uterine prolapse or cyctocel, grade 3 or above
Women with a history of pelvic surgery
Women with cardiac, respiratory or motor disorders
Women with a history of hysterectomy
Women with urinary tract infections or urinary stones
Women with chronic constipation
Women with some neurological diseases such as multiple sclerosis, Parkinson's, brain tumor, stroke, and spinal cord injury</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>N39.3</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Stress incontinence (female)</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Paula method, which includes a group of circular muscle exercises to return proper functioning of the body, allows to strengthen the pelvic floor muscles by contracting and expanding the circular muscles in other parts of the body such as the eyes, lips, hands and nose. Paula method will be taught to the elderly people via CD and a link to download educational videos and brochures, and the elderly people will be asked to do this method for 12 weeks and every week for 45 minutes. People are encouraged to perform this method daily for 15-45 minutes. Treatment companions can also contact the person in charge of the investigation in case of any questions or problems</i_keyword>
      <i_keyword>Intervention group: Kegel exercises is the contraction and expansion of the pelvic floor muscles and leads to strengthening of the pelvic floor muscles. These exercises last for 8 weeks and 10 sets a day. Each time involves 10-12 seconds of contraction and 10-12 seconds of rest</i_keyword>
      <i_keyword>Control group will receive the routine intervention in treatment centers</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>The amount of Bladder neck descent. Timepoint: Before the intervention and one week after the intervention in the Kegel group (ninth week) and one week after the intervention in the Paula and control groups (13th week). Method of measurement: Sonography.</prim_outcome>
      <prim_outcome>The amount of pressure in which urine leakage occurs. (VLPP). Timepoint: Before the intervention and one week after the intervention in the Kegel group (ninth week) and one week after the intervention in the Paula and control groups (13th week). Method of measurement: Sonography.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Pad weight. Timepoint: Before the intervention and one week after the intervention in the Kegel group (ninth week) and one week after the intervention in the Paula and control groups (13th week). Method of measurement: Notebook Digital scale machine.</sec_outcome>
      <sec_outcome>Stress urinary incontinence score in ICIQ-UI SF questionnaire. Timepoint: Before the intervention and one week after the intervention in the Kegel group (ninth week) and one week after the intervention in the Paula and control groups (13th week). Method of measurement: ICIQ-UI SF Questionnaire.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahroud University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2021-06-21</approval_date>
        <contact_name>Ethics committee of Shahroud University of Medical Sciences</contact_name>
        <contact_address>Haft-e Tir Sq, Shahroud University of Medical Sciences, Shahroud, Iran Shahroud Semnan Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
